$KRYS News

Krystal Biotech (NASDAQ:KRYS) Clears Minervini Trend Template and High Growth Momentum Screen

Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says

RBC Capital Initiates Coverage On Krystal Biotech with Outperform Rating, Announces Price Target of $400

Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript

If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today

Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run

Krystal Biotech, Inc. 2026 Q2 - Results - Earnings Call Presentation

Krystal Biotech, Inc. Q2 2026 Earnings Call Summary

Citigroup Maintains Buy on Krystal Biotech, Raises Price Target to $386

Krystal Biotech Inc (KRYS) (Q2 2026) Earnings Call Highlights: VYJUVEK Sales Surge 24% as ...

Krystal Biotech, Inc. (KRYS) Q2 2026 Earnings Call Transcript

Krystal Biotech Q2 Earnings Call Highlights

Krystal Biotech Shares Slide Despite Earnings Beat as Revenue Misses Forecasts

Krystal Biotech (NASDAQ:KRYS) Slips After Q2 Revenue Miss Despite EPS Beat

Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Beat Estimates

Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

Krystal Biotech Q2 EPS $1.79 Beats $1.66 Estimate, Sales $119.222M Miss $121.061M Estimate

Krystal Biotech (KRYS) Could Be 40% Overvalued As KB801 News Tests Its Price

Krystal Biotech (KRYS) Is Up 7.9% After S&P 400 Move And New KB801 Patent Filing Update

Krystal Biotech: International Expansion And A Vibrant Pipeline